Search results
Results from the WOW.Com Content Network
Is Viatris stock a buy? Viatris isn't and might never be a great pick for growth investors. However, I think it's a good choice for income investors, with its forward dividend yield of nearly 4% ...
In addition to its rock-bottom valuation, Viatris offers shareholders a hefty 4.12% dividend yield. The downside is Wall Street is projecting a 1.5% revenue decline for the drugmaker in 2025 ...
Until recently, Viatris (NASDAQ:VTRS) was considered a value play among drug stocks. But after its recent earnings report, and announced sale of a key asset? The generic drug maker has been deemed ...
Stocks with the highest dividend yields in the Dow Jones Industrial Average *Data below as of Jan. 9, 2025. 1. Verizon Communications (VZ) Verizon is a leader in communication and technology ...
On the dividend front, the pharmaceutical giant delivers a 3.25% yield supported by a healthy 64.4% payout ratio. The company's track record shows consistent dividend increases, with 7.68% annual ...
The dividend yield of the Dow Jones Industrial Average, which is obtained from the annual dividends of all 30 companies in the average divided by their cumulative stock price, has also been considered to be an important indicator of the strength of the U.S. stock market. Historically, the Dow Jones dividend yield has fluctuated between 3.2% ...
Image source: Getty Images. Annaly Capital Management: 13.14% yield. A second ultra-high-yield dividend stock that makes for a slam-dunk buy in the new year is mortgage real estate investment ...
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn , a legacy division of Pfizer , on November 16, 2020.